prostin e2
pfizer new zealand limited - dinoprostone 0.8 mg/ml - vaginal gel - 2mg/3g - active: dinoprostone 0.8 mg/ml excipient: colloidal silicon dioxide triacetin - prostin e2 is indicated for the induction of labour in term or near term women who have favourable induction features; and who have singleton pregnancy with a vertex position.
prostin e2 3mg vaginal tablets
pfizer healthcare ireland - dinoprostone - vaginal tablet - 3 milligram(s) - prostaglandins; dinoprostone
prostin e2 1mg/ml concentrate for solution for infusion
pfizer healthcare ireland - dinoprostone - concentrate for solution for infusion - 1 milligram(s)/millilitre - prostaglandins; dinoprostone
prostin e2 1 mg vaginal gel
pfizer healthcare ireland - dinoprostone - vaginal gel - 1 milligram(s) - prostaglandins; dinoprostone
prostin e2 2 mg vaginal gel
pfizer healthcare ireland - dinoprostone - vaginal gel - 2 milligram(s) - prostaglandins; dinoprostone
propess dinoprostone 10 mg pessary sachet
ferring pharmaceuticals pty ltd - dinoprostone -
propess 10 mg vaginal delivery system
ferring ireland ltd - dinoprostone - vaginal delivery system - 10 milligram(s) - prostaglandins; dinoprostone
prepidil 0.5 mg - 3 g endocervic. gel pre-filled syr.
pfizer sa-nv - dinoprostone 0,5 mg/3 g - endocervical gel - 0,5 mg - 3 g - dinoprostone 0.5 mg - dinoprostone
propess 10 mg vagin. delivery system sachet
ferring sa-nv - dinoprostone 10 mg - vaginal delivery system - 10 mg - dinoprostone 10 mg - dinoprostone
prostin e2 0.5 mg tabl.
pfizer sa-nv - dinoprostone 0,5 mg - tablet - 0,5 mg - dinoprostone 0.5 mg - dinoprostone